The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
Henry won the title in recognition of his work tackling bird flu, as the outbreak of this devastating disease spread across the country this summer.
A total of 140 nominations were received for this year’s Zoetis-sponsored award, which celebrates vets who have made a significant impact in the first stages of their professional career.
The judging panel comprised BVA President Anna Judson, Royal College of Veterinary Surgeons (RCVS) President Sue Paterson, National Veterinary Lead Ruminant and Equine at Zoetis UK Ally Ward, and last year’s award winner vet Hannah Hunt.
In addition to his work tackling bird flu, the judges also acknowledged Henry’s role in encouraging other young vets to join the poultry industry.
After graduating from the Royal Veterinary College (RVC) in 2018, he began working at Crowshall Veterinary Services, Norfolk, providing dedicated consultancy and Official Veterinarian (OV) provision to the poultry/gamebird industry across Great Britain and internationally.
This has seen him working through the recent bird flu outbreaks, holding multiple OV panels, and preparing for export changes associated with Brexit.
Henry is also a mental health first aider and trustee of regional rural mental health charity You Are Not Alone (YANA), deputy rotation lead for the new RVC poultry rotation, which takes its first students in 2024, and is also co-lead of his practice green group through which he has steered his practice to the top Green accreditation for sustainability with Investors in the Environment.
In his role as external lecturer for the RVC, Henry provides opportunities to engage with avian population medicine for new members of the profession.
Henry said: “To be named BVA Young Vet of the Year is a huge honour and it means all the more having heard about the outstanding work, dedication and skills of the other two finalists.
I’m delighted that after a challenging few years the poultry sector has been highlighted tonight, as all those involved have worked tirelessly to overcome the largest animal health outbreak the UK has experienced in recent times - I hope that winning this award will encourage more young vets to consider joining us in the poultry sector.
"It’s extremely rewarding work.”
Henry was shortlisted alongside vet Rebecca Hampson, who co-founded animal welfare charity Veterinary Education Malawi, and equine vet Camilla Church, who set up her own practice, Perth Equine Vets.
BVA President Anna Judson said: “The standard of nominations this year was outstanding. It sounds cliché, but we really did have our work cut out when choosing the finalists.”
Photo: Young Vet of the Year Henry Lamb with finalists Rebecca Hampson, BVA President Anna Judson and Camilla Church.jpg
Neurology Specialists Mark Lowrie and Laurent Garosi from Davies Veterinary Specialists and Robert Harvey from the UCL School of Pharmacy have discovered a new syndrome which causes noise-triggered seizures in old cats, dubbed FARS (feline audiogenic reflex seizures).
The discovery came about after the charity International Cat Care contacted Davies Veterinary Specialists for help with several enquiries it had received regarding cats having seizures, seemingly in response to certain high-pitched sounds. The problem was not documented and little, if anything, was known about it.
Mark, Laurent and Robert decided to investigate, and compiled a questionnaire for owners to complete. The research generated worldwide media interest (dubbed 'Tom and Jerry syndrome' after the cartoon character Tom who has a strong startle reflex and often reacts with involuntary jerks to sound stimuli), and they received hundreds of replies from across the globe from people who had noticed the same problem in their cats in response to certain types of sound. These owners had also found that their local vets had no information at all about it, and often did not believe that a sound had triggered the seizure.
The research has resulted in a paper, Audiogenic reflex seizures in cats, which is published in the Journal of Feline Medicine and Surgery.
The paper pulls together information from 96 of reported cases, looking at the type and duration of seizure and the triggering sound. The authors say it reveals that some cats do indeed suffer from audiogenic reflex seizures - those which are consistently caused by sounds (this is also recognised in people). Certain sounds induced 'absences' (non-convulsive seizures), myoclonic seizures (brief, shock-like jerks of a muscle or a group of muscles), or generalised tonic-clonic seizures. This last category is what most people think of as a 'seizure', with the cat losing consciousness and its body stiffening and jerking, often for several minutes. The new syndrome has been termed feline audiogenic reflex seizures (FARS).
The investigation found that FARS occurred in pedigree and non-pedigree cats, but that among the pedigrees, the Birman breed was over-represented. This is also a problem of older cats - the average age of seizure onset was 15 years, with cats ranging in age from 10 to 19 years.
The most commonly reported triggers for FARS were:
Other, less common triggers were the sound of breaking the tin foil from packaging, mobile phone texting and ringing, digital alarms, Velcro, stove igniting ticks, running water, a dog jangling its collar as it scratched, computer printer, firewood splitting, wooden blocks being knocked together, walking across a wooden floor with bare feet or squeaky shoes and, in one case, the short, sharp scream of a young child.
Avoiding the sounds could reduce the seizures, although owners reported that it was sometimes difficult to avoid certain sounds, and the loudness of the sound also seemed to increase the severity of seizures.
The geriatric nature of this condition is such that it may be overlooked in older cats, which may potentially suffer from other concurrent conditions. The hope is that publication of the paper will raise awareness among vets in practice about this syndrome. Meanwhile, work is ongoing to identify the genetic basis of this disorder and the team is now also working on a paper about treatment of these cases.
Lead author, Mark Lowrie, said: 'We have been overwhelmed by the response to our work. A second study is soon to be published suggesting that levetiracetam is an excellent choice of medication in managing this condition. Our experience is that it can completely rid a cat of these sound-induced seizures, including the myoclonic twitches - one owner reported that levetiracetam had 'truly been a miracle drug for my cat''.
Claire Bessant, Chief Executive of International Cat Care, summed up: 'How wonderful to be able to go back to those worried owners who came to us for help with a problem previously unrecognised by the veterinary profession with not only an explanation for their cats' behaviours, but a way to help them as well.'
The study can be read for free here: http://jfm.sagepub.com/content/early/2015/04/27/1098612X15582080.full.pdf+html
Reference
Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.
According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure because it helps reduce pulmonary oedema and its quick onset of action is associated with a noticeable reduction in clinical signs.
However, Ceva highlights the fact that long-term under or over-dosing can have profound health implications for the patient, and says that current recommendations are to reduce the dose to the minimum effective dose as soon as the animal is stable and only increase it if required due to deterioration in heart function.
Ceva says that unlike other furosemides, Libeo has been designed solely for the veterinary market - specifically to facilitate easy and accurate dosing.
The four-way break tablet is available in a traditional 40mg tablet size as well as a unique 10mg size for small patients. The clover-shaped tablet is chicken-flavoured, designed to make it easier for owners to dose their pets and help improve long-term owner compliance. Each box of Libeo contains 120 blister-packed tablets, removing the need for someone to have to count out tablets.
Rob McLintock MRCVS, Companion Animal Business Unit Manager at Ceva Animal Health said: “87% of vets in the UK believe that the dose of furosemide given to pets by their owners is adversely affected by how difficult it is to split the tablets1. This is especially likely to affect pets whose owners are less dextrous or have difficulties using their hands. Libeo is both easy to administer and effective, thereby improving owner compliance and the long term health and welfare of their pets.”
The webinars will take place every Wednesday at 7pm in May.
David Bardell is a European and Royal College of Veterinary Surgeons Specialist in Veterinary Anaesthesia and Analgesia and will be hosting the first two sessions covering equine pain management for colic and orthopaedic cases respectively.
The 5th May webinar will cover how to recognise and understand the pathology of visceral pain, physical and pharmacological methods of analgesia and dealing with violent or difficult colic cases.
The second webinar on the following Wednesday, will look at how to recognise and quantify pain, the use of pain scales, analgesic medication and techniques.
The other two sessions of the series will be led by Dr. Andy Fiske-Jackson, Deputy Head of RVC Equine and Senior Lecturer in Equine Surgery at the Royal Veterinary College. He'll be running case-based sessions looking at the good, bad and ugly of digital flexor tendon sheath cases and unravelling the diagnosis and treatment of navicular syndrome, the associated biomechanics and treatment options respectively.
Emma Jennings, Equine Brand Manager at Dechra (pictured right) said: “The broad scope of illnesses and conditions facing those specialising in equine care means that it’s important to delve deeper into some key issues, which is what this series of webinars will do.
“We hope the expertise of David Bardell and Dr. Andy Fiske-Jackson will be of key interest to veterinary professionals across the country and would urge anyone interested to register for the sessions throughout May.”
To register for the free webinars, visit www.dechra.co.uk/events.
Vetoquinol UK has launched Dolpac®, its new wormer for dogs.
Dolpac® is a broad spectrum anthelmintic for dogs containing pyrantel, oxantel and praziquantel. Individually these ingredients are effective against individual worm species and the combination of all three provides specific activities against the most common roundworm and tapeworm species.
According to the company, clinical studies carried out in accordance with internationally recognised guidelines have shown that Dolpac® provides an excellent ability to reduce parasitic infection.
“Dolpac® offers vets and their clients an easy to use worming alternative at an affordable price,” explains Mark Leddy, Vetoquinol’s Marketing Department Manager. “Our aim is to help to increase the number of dog owners worming their pets at the correct frequency, which will not only protect their dogs, but their children as well. We have introduced a number of features to help achieve this objective, there are three tablet sizes to cover all weight ranges and the tablets are flavoured and easy to give, and there are dispensing envelopes in every pack. We also provide a dosing wall chart and a client worming guide.”
For more information, contact your Vetoquinol representative or visit the Dolpac website, http://www.dolpac.co.uk/, which offers information for both vets and clients.
BCF Technology has launched a competition in which the person who submits the best photograph with the theme of: All in a day's work - animal imaging, will win an iPad 2.
To enter the competition, you need to post your photographs, (and tell BCF a little about the story behind the images) at www.facebook.com/bcftechnology or email them to: info@bcftechnology.com
Jason Rogers, Marketing Manager at BCF said: "We wanted to create a fun way to show just how interesting and different each days work is when imaging animals. We have made the competition open to all that work with animal imaging including our staff, dealers and vets, vet nurses, animal contractors, etc from all over the world.
"It is great to see the BCF office in the States and our international dealers also promoting the competition in their own countries, making the competition truly international. Response to the competition has been fantastic - see our facebook page to some entries for yourself."
The closing date for the competition is 30th September 2011.
For more information, visit: www.bcftechnology.com
BEVA has announced that tickets are now on sale for BEVA Congress and members who register before 4th August 2016 can benefit from big discounts.
This year, BEVA Congress is being held at the ICC in central Birmingham.
In addition to the clinical programme, tactics to achieve the elusive work life balance and the applicability of evidence based medicine are recurring themes over the three days of the event.
Five separate programmes will run concurrently in five adjacent halls, deploying a mix of traditional lectures, panel discussions and interactive forums to suit equine vets and mixed practitioners at any stage in their career. Vet nurses, farriers, equine physiotherapists and equine dental technicians can also attend specific sessions focused on their areas of expertise.
There will be daily practical sessions in the exhibition hall: Jonathan Anderson, Will Barker, Tim Barnett, Ollie Crowe, Richard Reardon, Neil Townsend and Thomas Witte will be demonstrating sinoscopy and gastroscopy techniques and delegates will have the chance to roll up their sleeves and get hands on with dead heads and digital models.
Programme highlights include a day of advanced orthopaedics in combination with the European Society of Veterinary Orthopaedics and Traumatology (ESVOT). The sessions will draw on canine and human experience, with speakers including Ian Wright from the Newmarket Equine Hospital, Peter Clegg from the University of Liverpool, Wayne McIlwraith from Colorado State University and Martin Waselau from Equine Hospital Aschheim, Germany.
There will also be career and practice development sessions exploring what you can do with your veterinary degree, how to look after your staff and how to take advantage of smartphone technology in practice. Evidence in surgery and critical appraisal tools will be explored in a series of presentations on two separate days across a wide range of conditions. Speakers will include Will Barker, Bruce McGorum, and Etienne O'Brien.
Kathy Clarke, Professor of Veterinary Anaesthesia at the Royal Veterinary College, will be giving the plenary lecture on from the difficult horse to the demanding surgeon; how effective sedation has revolutionised what is achievable in equine clinical practice. There will be a debate on the Friday with Victoria Harris chairing the promisingly divisive This house believes that lab tests are overused and abused.
There will also be comprehensive sessions on parasitology, laminitis, skin disease, anaesthesia and analgesia, colic, respiratory disease, sports injuries, standing surgery, ophthalmology, diagnostics, wounds, neurology and differentiating lameness from neurological disease, mare and foal, reproduction, dentistry, gastro intestinal disease and nutrition, cardiology and medicine.
Saturday’s vet nurse sessions will cover surgical management, emergency patients, the use of antimicrobials and adjunctive therapies. In addition, daily clinical research presentations will provide exclusive opportunities to hear about novel and exciting research projects.
There's a free BEVA Congress App with the full scientific programme and to help you manage your day. And if you are struggling for time or torn between several lectures you can use the BEVA Congress Encore Room which gives you the chance to play back missed lectures at your convenience.
For more information, visit www.beva.org.uk.
Alex is applying the data science he uses in his day job to help local vets at the Olive Ridley Project care for the ancient reptiles.
Six of the seven species of sea turtles are endangered due to human behaviour, many of them killed by poachers for their shells, eggs and meat.
They're also affected by the increasing volume of plastic waste in the sea.
Alex, who normally spends his time leading a team of business intelligence engineers and analysts who provide insights in finance, HR and clinical event reporting, is setting the charity up with practice management software to help it capture clinical records and track the sea turtles.
Alex said: "We’ll be setting up the software, making sure the vets can operate it and then adding all their existing data to it. We’re giving them a powerful tool to capture clinical records and manage turtles over a long period of time.”
“These valuable creatures are hugely important to marine ecosystems and have travelled our seas for the last 100 million years, so I’m delighted to be able to play a part in their conservation.”
For more information on the Olive Ridley Project, visit https://oliveridleyproject.org.
Humanimal Trust is the only organisation in the UK with the sole purpose of progressing One Medicine, driving collaboration between vets, doctors, nurses and researchers so advances in both human and animal medicine can be achieved faster.
The seminar, entitled One Medicine in Action – Awareness, Collaboration and Change, follows on from the Trust’s inaugural symposium last year when a roadmap was created on how to develop closer links between human and veterinary medical and research professionals.
This year’s event will look at ways to put the roadmap into action through awareness raising, increased collaboration and change.
Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust (pictured right), said “We know that when animal and human health professionals and scientists come together, great things happen.
"Last year’s symposium, which was part of our ‘Stronger Together’ campaign, was a huge success.
"It drew an audience from across the UK and Europe, as well as Chile, the United States, Singapore and Australia.
“Not only did it provide a real opportunity to explore ways to achieve more ethical and fair medical progress for all, but it also allowed connections to be made and relationships to be forged that wouldn’t otherwise exist.”
Miss Anna Radford, a Consultant in Paediatric Surgery at Hull University NHS Trust and Leeds Children’s Hospital, who is speaking at the seminar in May, said: “I was introduced to a diagnostics company working in the animal medical care field at last year’s symposium and through them, we have set up a new collaboration with the aim of determining whether this sort of diagnostic technology developed with companion animal medicine in mind, could potentially also be useful to help diagnose urinary, joint and cerebrospinal fluid infections in a busy NHS hospital setting.”
Other speakers at this year’s event include Dr Deborah Thomson, Founder and President of One Health Lessons, an organisation that inspires children and adults around the world to value the interconnection between human health and the health of the environment, plants and animals.
Dr Simon Doherty, a Senior Lecturer at the Institute of Global Food Security at Queen’s University in Belfast will highlight organisations that are successfully working together to improve the sustainability of dairy, meat and fish production to feed a growing global population, as well as the opportunities that exist for collaboration within the agri-food sector.
Dr Doug Brown, CEO of the British Society for Immunology, will share some of the most notable examples of joined-up approaches in human and animal health research from across the Society’s membership, with a particular focus on veterinary immunology.
The seminar, which will run from 2pm until 5.15pm BST, will end with a panel Q&A session, chaired by Humanimal Trust Trustee and Consultant Respiratory Physician at the University Hospital Southampton NHS Foundation Trust, Dr Ben Marshall.
Attendance is free and registration is now open to all human and veterinary medical professionals and students, and the allied health and scientific disciplines.
To find out more and register, visit www.humanimaltrust.org.uk
It seems that a series of one day conferences, organised by the Animal Health agency for vets and animal health inspectors involved in fighting bovine TB, haven't gone down as well as hoped.
According to a report in yesterday's Daily Telegraph, many in the audience were angered when they were asked to spend up to an hour playing a game involving bongo drums.
Incredibly, a spokesman for Animal Health apparently told the Daily Telegraph that: "It was meant to emphasise how people working together can build up a rhythm."
Boehringer Ingelheim Vetmedica has launched new, more palatable Metacam Chewable Tablets.
According to the company, the tablets are proven to be taken by 90% of dogs voluntarily1 and 80% will even take them from the floor1 which aids compliance. Available in pop-through blister strips of seven for easy dispensing and administration, the 1mg and 2.5mg Metacam Chewable Tablets are packed in boxes of 84 and priced the same per tablet as the current tablet range.
Claire Fowler, companion animal marketing manager at Boehringer Ingelheim, said: "The existing Metacam Chewable Tablets are readily accepted by most dogs. However, to appeal to as many dogs as possible, we have launched an even more appetising 'beefed up' meaty flavour."
For further information on the new flavoured Metacam tablets, including special offers, please contact your Boehringer Ingelheim territory manager or call 01344 746959.
Fearne, who has been presenting live TV since she was 15 years old, has published eight books including the top 10 bestseller 'Happy', in which she talks about her own experiences of happiness and advocates raising awareness around the many ways people can build their own resilience and maintain good mental wellbeing.
Fearne has recently been appointed as a Princes Trust Goodwill Ambassador where she will be focussing on young peoples’ wellbeing and mental health.
She is also an ambassador for the charity Mind and has spoken about her wish to help stop the subject of depression being such a taboo.
Noel Fitzpatrick said: "We are absolutely thrilled that Fearne is joining us for the VETFest Conversation this year, continuing on what has become an integral and enlightening fulcrum of the wellness program of our event schedule.
"It means a great deal to myself and the organisers that all delegates who attend VET Festival have a very special and personally enriching experience - but they also feel part of a wider community of compassion too - within the industry among their peers but in a broader societal sense as well.
"With Fearne, we will explore many themes about health and well-being relevant to all of us. We hope to make you think, laugh and have a great time, and impart some wellness to take home into day to day life as well."
The VETFest Conversation is open to all delegates at VET Festival and takes place after the clinical programme on Friday 8th June at 6.00pm – 6.45pm.
You can book tickets for the event here: https://www.vetfestival.co.uk/delegate-info/ticket-information
BCF Technology has announced that it now has the 9020HF ultralight and the 10040HF ultra orange x-ray generators available in blue.
Jason Rogers of BCF said: "Our range of generators aims to meet the needs of any size of veterinary practice. The new blue generators will compliment our existing range. The bright blue colour means they will be eye-catching in the field, meaning you wont leave them behind!"
What next? The BCF Spring Collection - a range of ultrasound scanners in pale, neutral shades guaranteed not to clash with your overalls?
To find out more about BCF Technology's range of x-ray equipment and generators visit http://www.bcftechnology.com/
Pfizer Animal Health has launched Poulvac, the first modified live vaccine against E.coli in chickens.
The company claims that the vaccine, which can be used from one day of age, is set to bring major benefits in safeguarding the health of broilers, pullets for egg laying and breeding stock.
According to Pfizer, E.coli is one of the most significant bacterial pathogens found in chicks during the first week, leading to problems throughout the life of a flock including inferior performance, lack of uniformity and increased mortality. It is a costly, widespread problem for the UK poultry industry.
The vaccine was developed from research beginning in the 1990s at the Government's veterinary laboratories at Weybridge (now AHVLA) in the UK, employing genome technology to produce an avirulent strain of E.coli that induces protective immunity to the pathogenic strains of the bacteria.
The vaccine is completely non-pathogenic, and does not persist in the bird or the environment for any significant period of time. A gene deletion in its development restricts in vivo replication and leaves behind activated macrophages ready to respond to pathogenic E.coli strains.
Dr Stuart Andrews, poultry technical manager of Pfizer in the UK and Ireland said: "Poulvac E. coli provides broad cross protection against the key serotypes of E. coli infecting chickens. It is the only modified live, nonreactive vaccine proven to meet the European regulatory requirements for efficacy and safety.
"Trials have confirmed that Poulvac E.coli does not persist in the bird and proves to be self-limiting. The vaccine can survive in the environment for only a short time, and spread to in-contact birds is also limited."
The vaccine is administered as a coarse spray with onset of immunity 14 days afterwards and duration of immunity for up to 12 weeks. It can be used from day-old up to six weeks before the onset of lay, and has a nil day withdrawal period.
In the USA where Poulvac E coli has been available for six years field experience has shown the considerable benefits. In the Midwest where average layer mortality at 50 weeks of age was 2.31 per cent, this was reduced to 1.51 per cent with three doses of the vaccine*. In Eastern USA flock mortality compared with five previous flocks was reduced from over three per cent to one per cent.
A field trial in the USA with more than 300,000 broiler breeders vaccination before lay reduced mortality from 2.8 to 1.9 per cent - with only two out of 28 flocks needing antibiotic treatment compared with 13 of the 28 unvaccinated flocks.
On a broiler field trial in Georgia over four million birds were vaccinated with Poulvac E. coli at hatch. The vaccinated birds had a better feed conversion (1.79 against 1.84 for the controls) and with condemnations at the processing plant down from 1.22 to 0.73 per cent the result was a lower production cost of 0.51¢ per lb.
In another broiler trial covering more than two million birds in Arkansas livability was improved from 95.20 to 95.77 per cent and feed conversion improved from 1.95 to 1.90, gaining 0.45¢ per lb.
* Pfizer says it is important to note that in these studies carried out in the USA more than one dose of the vaccine was often administered. A single vaccination is licensed in the Summary of Product Characteristics however, where clinical disease requires and at the discretion of a veterinary surgeon, the vaccination schedule may be re-started as there is no contra-indication on the SPC.
Luke will receive his award at the 2016 WSAVA World Congress, which takes place from 27-30 September in Cartagena, Colombia, where he will also give a lecture on his work, entitled ‘One Mission’.
The WSAVA Global One Health Award is presented by the WSAVA’s One Health Committee (OHC) to an individual who has promoted an aspect of One Health relevant to small companion animals.
Luke graduated from Bristol University in 1999 and is based in his New Forest surgery, Pilgrims Veterinary Practice. In 2003, he set up Worldwide Veterinary Service (WVS), a charity providing veterinary aid around the world, followed, in 2013, by sister charity, Mission Rabies, which is leading the battle against canine rabies and works closely with the WSAVA’s charitable Foundation. Luke is CEO of both organisations and has raised more than four million pounds to support the charities’ projects around the world. He lectures internationally on animal welfare and veterinary subjects and, in 2014, was asked by the World Health Organisation (WHO) to sit on an expert panel for the International Control of Neglected Zoonotic Diseases based on his rabies work globally.
Professor Michael Day, Chair of the WSAVA OHC, said: "The current most significant example of the importance of a One Health approach to disease control relates to the global fight against canine rabies - a disease that continues to cause an estimated minimum 59,000 human deaths each year. Luke is a world leader in this global fight. Mission Rabies runs mass vaccination campaigns and provides public education in Asia and Africa, having now vaccinated almost 400,000 dogs, spoken to over 500,000 schoolchildren and successfully controlled rabies in selected target areas.
"The Mission Rabies programme is grounded in solid evidence-based science, with the field data collected having now generated the first high-class scientific manuscripts. Luke is a truly inspirational and charismatic leader who believes in simply getting on with the job at hand. The achievements of Mission Rabies and its sister charity, Worldwide Veterinary Service, readily show that even the greatest global health challenges are not insurmountable."
Luke said: "It’s a huge honour to receive this Award and I accept it on behalf of an amazing team - without whom - the projects would be impossible. It’s an utter privilege to be a part of the veterinary profession and fighting diseases like rabies is an incredible opportunity to champion both animals and people – something we can all identify with. I’m totally indebted to WSAVA and the international veterinary community, whose support has been overwhelming, and it is only with this unity, that we can keep driving forward – and winning."
Owners are being asked to provide a photo or video and a brief description that capture what it is like to live with and care for an older dog.
Dr Carri Westgarth, a senior lecturer in human-animal interaction at the University of Liverpool, has been awarded a citizen science grant from PetSavers to run the project. She plans to use the information gathered to help develop a ‘Canine Ageing and Wellbeing’ tool for use in veterinary practice.
Carri said: “Dogs are living up to twice as long as they did 40 years ago and there are implications for senior dogs’ healthcare and wellbeing.
"As life expectancy increases, so does the amount of time the dog may spend in poor health. It may be difficult for us to distinguish between the signs of serious age-related diseases and normal age-related changes in our dogs."
PetSavers says the data will contribute to our investigations of owner expectations, experiences and attitudes to ageing in dogs, including preventative care and general understanding of normal and abnormal changes during ageing.
Carri added: "Improving discussions between owners and veterinary professionals about senior dog care will help to increase owner understanding and involvement in care decisions for their pet. The resulting early detection of health problems should bring significant improvement to the quality of life of senior pets and the dog-owner relationship.
"Any adult UK residents who (currently or recently) live with an aged dog/s of any breed/s or health status are encouraged to participate by choosing an image or short video and telling us about it."
The research team will then analyse the submitted text and media for common themes. They may also use anonymised selected quotes to illustrate important findings in research publications such as scientific papers or conference presentations.
If you know any owners who might like to participate, do share this link with them: https://bit.ly/PetSaversOAPsPhoto
For more information, visit: https://www.petsavers.org.uk/our-research/oldagepets
Data collection will close on Friday 10th July 2020.
The service will be run by European and RCVS recognised specialist in Soft Tissue Surgery, Jane Ladlow, and will begin taking referrals from October 28th.
Jane has nearly 20 years’ experience as a specialist clinician, researcher, teacher and lecturer.
Her main focus for the last 10 years has been upper airway disease in dogs. As the clinical lead of the Cambridge Brachycephalic Obstructive Airway Syndrome (BOAS) Research Group, she has been instrumental in the introduction of objective, non-invasive assessments of airway function, identifying risk factors for BOAS, clinical diagnosis, breeding guidelines and the development of new surgical techniques (laser turbinectomy and laryngeal surgeries).
She has extensive experience of general surgery, and particularly enjoys oncology surgery, with an emphasis on treatments that are kind to owners and animals. Jane was the 2019 recipient of the BSAVA Simon Award for outstanding contributions in the field of veterinary surgery.
Jane said, “The team at HSR demonstrate a drive for excellence, both clinically and in providing the best experience for clients and their pets. I’m excited to start working as part of the innovative and collaborative team of surgeons, nurses and support staff.”
Director and orthopaedic surgery specialist, Michael Hamilton, said: “We’re absolutely delighted to welcome Jane to the team here. Her work has revolutionised the way we diagnose and manage BOAS. Continual learning and innovation are core to our practice, and we know Jane will be a strong driving force helping us continue providing the best outcomes for clients and their pets.”
For more information, visit: www.hamiltonspecialists.vet
"Advances in Imaging of the Equine Distal Limb 2017–2022" comprises a total of 20 papers which have been selected by Mathieu Spriet, Ann Carstens and Tim Mair.
It also includes an editorial from the EVJ summarising the major historical technological developments in imaging of the foot and fetlock.
The publication looks at the evolution of computed tomography (CT), positron emission tomography (PET), which has opened a whole new field of possibilities for bone and soft tissue imaging in racehorses and sport horses, MRI and how it has been improved by optimising scanning techniques, ultrasound radiography and scintigraphy.
Mathieu Spriet said: “The content of this virtual issue represents an amazing amount of new knowledge that with no doubt will contribute to improve equine welfare and safety.
“With the increase availability and versatility of all the imaging modalities, the knowledge base appears to increase exponentially.
"We are very excited to see what the next five years will bring. We hope the readers will enjoy consulting this collection as much as we enjoyed putting it together.”
The virtual issue is free for 12 weeks and can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.equine-distal-limb
Photo: 18F-NaF PET, CT and MRI images from a horse with navicular and middle phalanx lesions. Adapted from EVJ 2018;50: 125-132
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
Norbrook Laboratories Ltd has announced the launch of Pestigon, a fipronil spot-on solution for cats and dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Pestigon offers a fast-acting and long-lasting treatment for cats and dogs suffering from flea and tick irritations. The new product will have an immediate effect against flea infestations and will kill ticks within the first 24 - 48 hours of application. Fipronil is a tried and tested ingredient with proven efficacy against fleas and ticks. Pestigon provides a fast-acting treatment whose effectiveness will continue against new infestations of fleas for up to 58 days on dogs and 37 days in cats and against ticks for up to 30 days in dogs and 21 days in cats."
To coincide with the launch of Pestigon, Norbrook has rebranded its Permaguard household spray which is now available with 12 month protection.
Rebekah said: "The total life cycle of a flea can last from a couple of weeks to several months. Only adult fleas live on cats or dogs while the eggs, larvae and pupae can be found around the house in carpet, furniture, bedding etc for up to a year or more. It is therefore crucial that pet owners treat the household to break the life cycle and ensure effective and lasting flea control. Pestigon and Permaguard together will give pet owners a complete treatment."
Pestigon range offers 5 alternatives for cats and dogs depending on size and comes with colour co-ordinated pipettes available in packs of 3, 6 and 24 to allow for single or multiple pipette dispensing.
Norbrook's Small Animal Brand Manager, Michelle Jones said: "Pestigon is licensed as a POM-V product and will be sold exclusively through veterinary practices. We have produced a range of marketing materials for veterinary practices to help them offer support on flea and tick control in the home to their customers."
Orders for Pestigon and Permaguard can be placed through your Norbrook representative now.
The puppy journal, which was written with behaviourist and author, Gwen Bailey, contains information on puppy ownership including: a checklist of things to buy, top tips for bringing a puppy home, training and socialisation, toilet training, dental advice, skincare advice and behavioural advice.
The kitten journal has information about settling a kitten into a new home, hints and tips on toilet training, going outside for the first time and what behaviour to expect as kittens and cats get older.
Both journals include vaccination records, a place to keep favourite memories and important puppy and kitten dates.
They also have a voucher for a two-for-one offer on an Adaptil Junior collar or a Feliway Optimum refill.
Gwen Bailey said: "The first few weeks of a puppy and kitten’s life is undoubtedly the most important as they are learning a new way of life with their new family.
"The new puppy and kitten journals will provide new owners with helpful hints and tips to help them settle their new pet as quickly and smoothly as possible into their new home and enable owners to understand the principles of raising their puppy and kitten so they will enjoy their company for many years to come.”
To order copies of the puppy or kitten journals, contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
Andy, who was previously the Junior Vice Chair of the association, has been a member of BVOA for over 25 years, during which time he's been instrumental in organising scientific meetings and starting the popular BVOA discussion forum.
He is an RCVS and ECVS Specialist and in 2017 was made a Fellow of the RCVS for meritorious contributions to clinical practice.
He has taught numerous surgical residents and is widely published in many areas of orthopaedic surgery.
In 2023 he opened the Moores Orthopaedic Clinic, a dedicated orthopaedic-only referral clinic near Basingstoke in Hampshire.
Andy said: “It’s a great honour to take on the role of chairman for an organisation that I am so fond of.
“I am passionate about education and have taught, lectured and published widely.
"In my role at the Moores Orthopaedic Clinic I am always happy to discuss cases and assist colleagues as much as possible.
"I truly believe sharing knowledge is essential to successful patient outcomes, and BVOA allows this in numerous ways.
"My thanks go out to the rest of the BVOA committee for continuing to ensure we have a strong and vibrant Association, especially to Mark Bush my predecessor and to Sarah Girling who has left the committee this year after serving as Senior Vice Chair.”
All veterinary professionals with an interest in orthopaedics are welcomed and encouraged to join BVOA.
https://bvoa.co.uk/
Under the direction of Hilary Jackson and Rosanna Marsella, the manual has been revised and updated to provide a resource focused on the clinically relevant aspects of dermatological diseases. It also includes several new chapters and various sections have been expanded.
This new edition keeps the same format as the third edition. The initial chapters review the basic structure and function of the skin, discuss a logical approach to history-taking and outline the core investigative tests that can be performed. A separate chapter on skin cytology has been added to this edition, providing information on common skin diseases which the association says should be useful to all practitioners.
The introductory section is followed by chapters taking a problem-oriented approach to common dermatological conditions, including papules and pustules, scaling, and erosions and ulcerations. The chapters on pyoderma, ear disease and atopic dermatitis have been expanded and there are two new chapters dedicated to feline dermatological conditions.
A chapter covering the indications for allergy testing and the use of allergen-specific immunotherapy is also new to this edition. The main purpose of an allergy test is to confirm the clinical diagnosis of atopic disease and to identify the relevant allergens, which can then be selected for allergen-specific immunotherapy.
The final section of the manual focuses on the major skin diseases encountered in dogs and cats, and includes a chapter on topical treatments, which have an increasingly important role in the management of small animal dermatology patients, either as a sole therapy or as part of a multimodal treatment regime.
The BSAVA Manual of Canine and Feline Dermatology is available as a print edition (£90; £60 to BSAVA members), which can be bought at the BSAVA online shop, and a digital edition (£90; £60 to BSAVA members), accessible via the BSAVA Library.